↓ Skip to main content

Autoantibodies to aberrantly glycosylated MUC1 in early stage breast cancer are associated with a better prognosis

Overview of attention for article published in Breast Cancer Research, March 2011
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (71st percentile)
  • Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

patent
2 patents

Citations

dimensions_citation
164 Dimensions

Readers on

mendeley
119 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Autoantibodies to aberrantly glycosylated MUC1 in early stage breast cancer are associated with a better prognosis
Published in
Breast Cancer Research, March 2011
DOI 10.1186/bcr2841
Pubmed ID
Authors

Ola Blixt, Deanna Bueti, Brian Burford, Diane Allen, Sylvain Julien, Michael Hollingsworth, Alex Gammerman, Ian Fentiman, Joyce Taylor-Papadimitriou, Joy M Burchell

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 119 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 2%
Malaysia 1 <1%
Denmark 1 <1%
Germany 1 <1%
Unknown 114 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 31 26%
Student > Ph. D. Student 29 24%
Student > Master 11 9%
Student > Bachelor 10 8%
Professor 5 4%
Other 18 15%
Unknown 15 13%
Readers by discipline Count As %
Agricultural and Biological Sciences 26 22%
Biochemistry, Genetics and Molecular Biology 21 18%
Medicine and Dentistry 17 14%
Chemistry 15 13%
Immunology and Microbiology 6 5%
Other 11 9%
Unknown 23 19%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 November 2020.
All research outputs
#5,447,195
of 25,374,917 outputs
Outputs from Breast Cancer Research
#643
of 2,053 outputs
Outputs of similar age
#26,061
of 119,683 outputs
Outputs of similar age from Breast Cancer Research
#8
of 25 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,053 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.2. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 119,683 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.
We're also able to compare this research output to 25 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.